Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas

Published:2023-02-28 Issue:5 Volume:33 Page:3455-3466
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Pei Dongling,Guan Fangzhan,Hong Xuanke,Liu Zhen,Wang Weiwei,Qiu Yuning,Duan Wenchao,Wang Minkai,Sun Chen,Wang Wenqing,Wang Xiangxiang,Guo Yu,Wang Zilong,Liu Zhongyi,Xing Aoqi,Guo Zhixuan,Luo Lin,Liu Xianzhi,Cheng Jingliang,Zhang Bin,Zhang Zhenyu,Yan Jing^ORCID

Funder

National Natural Science Foundation of China

the Excellent Youth Talent Cultivation Program of Innovation in Health Science and Technology of Henan Province

the Key Program of Medical Science and Technique Foundation of Henan Province

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-023-09459-6.pdf

Reference36 articles.

1. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

2. Stupp R, Hegi ME, Mason WP et al (2009) European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

3. Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458–468

4. Louis DN, Perry A, Wesseling P, et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 29:noab106

5. Cairncross JG, Wang M, Jenkins RB et al (2014) Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol 32:783–790

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiogenomics: bridging the gap between imaging and genomics for precision oncology;MedComm;2024-09

2. Biologically interpretable multi-task deep learning pipeline predicts molecular alterations, grade, and prognosis in glioma patients;npj Precision Oncology;2024-08-16

3. Novel Imaging Approaches for Glioma Classification in the Era of the World Health Organization 2021 Update: A Scoping Review;Cancers;2024-05-08

4. Latest Developments in Magnetic Resonance Imaging for Evaluating the Molecular Microenvironment of Gliomas;Current Medical Imaging Formerly Current Medical Imaging Reviews;2024-04-17

5. Biologically interpretable multi-task deep learning pipeline predicts molecular alterations, grade, and prognosis in glioma patients;2024-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3